Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Exscientia Ltd ADR (NQ: EXAI )

4.690 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Nov 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Exscientia Ltd ADR

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Unlocking AI investment opportunities in healthcare
AI is revolutionizing healthcare by improving diagnosis and accelerating drug discovery. An often-overlooked sector with a wealth of AI opportunities. 
Via MarketBeat
Topics Artificial Intelligence ETFs
Exposures Artificial Intelligence
3 Cutting-Edge Biotech Stocks for the Bold Investor
With broader market concerns rising, investors may want to consider the relatively insulated allure of biotech stocks to buy. 
Via InvestorPlace
Exscientia Business Update for Third Quarter 2023
From Exscientia plc
Via Business Wire
Earnings Outlook For Exscientia
Via Benzinga
Exscientia to Report Third Quarter 2023 Financial Results on November 9, 2023
From Exscientia plc
Via Business Wire
Analyst Expectations for Exscientia's Future
Via Benzinga
A Preview Of Exscientia's Earnings
Via Benzinga
3 Trends in Artificial Intelligence to Watch in 2024
Three of the most important AI trends will involve its role in enhancing autos and healthcare, as well as the development of localized AI. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Parker Moss to Join Exscientia as EVP, Corporate Development
From Exscientia plc
Via Business Wire
Exscientia to Present New Preclinical Data for AI-designed LSD1 and MALT1 Inhibitors at ESMO 2023
From Exscientia plc
Via Business Wire
AZZ, VOXX International And Other Big Stocks Moving Higher On Wednesday
U.S. stocks traded higher Wednesday, with the Dow Jones gaining around 100 points. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Topics Stocks
Exposures US Equities
Why Astra Space Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Tempest Therapeutics, Inc. (NASDAQ: TPST) shares jumped 1067% to $2.80 after the company released new data demonstrating superiority of TPST-1120 arm across multiple study endpoints in... 
Via Benzinga
Exscientia Details Pipeline Prioritisation Strategy
From Exscientia plc
Via Business Wire
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring But Not Talking About Yet
Investors are constantly on the hunt for undervalued, under-followed, and emerging stocks. With countless methods available to retail traders, the challenge often lies in sifting through the abundance... 
Via Benzinga
Why Seelos Therapeutics Shares Are Trading Lower By 31%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers MSP Recovery, Inc. (NASDAQ: LIFW) shares climbed 81.5% to $0.2793 after jumping 64% on Wednesday. 
Via Benzinga
FedEx, Splunk, FactSet Research And Other Big Stocks Moving Higher On Thursday
U.S. stocks traded lower, with the Nasdaq Composite falling over 1% on Thursday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Exscientia Shares Surge On AI Collaboration: The Details
Exscientia Plc (NASDAQ: EXAI) shares are trading higher Wednesday after the company announced an AI drug discovery collaboration with Merck KGaA, 
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Why Fresh Tracks Therapeutics Shares Are Trading Higher By Around 53%; Here Are 20 Stocks Moving Premarket
Gainers TransCode Therapeutics, Inc. (NASDAQ: RNAZ) shares rose 70.2% to $0.8937 in pre-market trading after falling 10% on Tuesday. 
Via Benzinga
Exscientia Announces AI Drug Discovery Collaboration with Merck KGaA, Darmstadt, Germany
From Exscientia plc
Via Business Wire
3 AI Drug Discovery Stocks to Watch
The high cost of developing drugs makes the use of artificial intelligence a natural fit for pharmaceutical companies. 
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
3 Med Tech Stocks That the AI Boom Will Only Help
Med tech stocks are integrating artificial intelligence, adding substantial value for patients and investors in the near future. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Exscientia to Present at Upcoming Investor Conferences in September
From Exscientia plc
Via Business Wire
Biotech Breakthroughs: 3 Companies on the Cusp of Major Discoveries
Here are just a few top biotech stocks that may be on the cusp of major, game-changing discoveries, thanks to AI. 
Via InvestorPlace
Exscientia Business Update for Second Quarter and First Half of 2023
From Exscientia plc
Via Business Wire
3 AI Stocks Billionaires Are Loading Up On
With investors pouring funds into AI, it makes sense to consider snapping up the top AI stocks billionaires buy. 
Via InvestorPlace
Exscientia to Report Second Quarter 2023 Financial Results on August 10, 2023
From Exscientia
Via Business Wire
Here are 3 AI Drug Discovery Stocks to Put on Your Watchlist
Artificial intelligence (AI) has hit the mainstream with fervor. Specifically, generative AI has gone viral with the explosion in ChatGPT users. 
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
3 Millionaire-Maker Biotech Stocks to Buy Before the Window Closes
Here are three millionaire maker drug stocks from companies whose drugs could make truly staggering profits. 
Via InvestorPlace
MarketBeat Week in Review – 7/24 - 7/28
Investors continue to look for stocks to buy as inflation cools. As you prepare for another busy week, here are some of our top stories from this week 
Via MarketBeat
Topics Economy
Exposures Interest Rates
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.